Anebulo Pharmaceuticals, Inc. (ANEB) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $12.15M | +198.2% |
| 2024 | $4.07M | -65.1% |
| 2023 | $11.67M | -25.1% |
| 2022 | $15.58M | -28.1% |
| 2021 | $21.65M | +615.0% |
| 2020 | $3.03M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $12.15M | +198.2% |
| 2024 | $4.07M | -65.1% |
| 2023 | $11.67M | -25.1% |
| 2022 | $15.58M | -28.1% |
| 2021 | $21.65M | +615.0% |
| 2020 | $3.03M | — |